Sale!

CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 NGS Genetic DNA Test is a cutting-edge diagnostic tool that identifies mutations in the CALR3 gene associated with familial hypertrophic cardiomyopathy type 19. This comprehensive test utilizes next-generation sequencing technology to detect genetic variations that can lead to abnormal heart muscle thickening, potentially causing serious cardiovascular complications. Individuals with family history of heart conditions, unexplained cardiac symptoms, or those planning pregnancy should consider this test. Early detection enables proactive management, personalized treatment plans, and informed family planning decisions. The test provides valuable insights for cardiologists and genetic counselors to develop targeted prevention strategies. Results are typically available within 3-4 weeks from blood or DNA samples. This essential genetic screening is available for $500 USD, offering significant savings from the regular $700 price.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 NGS Genetic DNA Test

Comprehensive Genetic Testing for Heart Health

The CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing method specifically targets mutations in the CALR3 gene, which plays a crucial role in cardiac muscle function and development. Familial hypertrophic cardiomyopathy type 19 is an inherited condition characterized by abnormal thickening of the heart muscle, potentially leading to serious complications including arrhythmias, heart failure, and sudden cardiac death.

What This Test Measures and Detects

Our comprehensive NGS (Next-Generation Sequencing) genetic test specifically analyzes:

  • Complete sequencing of the CALR3 gene for pathogenic variants
  • Detection of single nucleotide polymorphisms (SNPs) associated with cardiomyopathy
  • Identification of insertions, deletions, and missense mutations
  • Assessment of genetic markers linked to hypertrophic cardiomyopathy progression
  • Evaluation of inherited patterns through family genetic analysis

Who Should Consider This Genetic Test?

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Unexplained chest pain or discomfort during physical activity
  • Family history of sudden cardiac death or heart conditions
  • Abnormal heart rhythms or palpitations without clear cause
  • Shortness of breath during routine activities
  • Dizziness, fainting spells, or lightheadedness
  • Abnormal echocardiogram results showing heart muscle thickening
  • Planning pregnancy with family history of cardiac conditions
  • First-degree relatives diagnosed with hypertrophic cardiomyopathy

Significant Benefits of Early Detection

Proactive Heart Health Management

Undergoing the CALR3 genetic test provides numerous advantages:

  • Early Intervention Opportunities: Detect genetic predisposition before symptoms manifest
  • Personalized Treatment Plans: Tailor medications and lifestyle recommendations based on genetic profile
  • Family Planning Guidance: Make informed decisions about genetic inheritance risks
  • Preventive Care Strategies: Implement targeted monitoring and preventive measures
  • Peace of Mind: Reduce uncertainty about genetic heart disease risks
  • Comprehensive Risk Assessment: Understand your complete cardiovascular genetic profile

Understanding Your Test Results

Interpreting Genetic Findings

Your test results will be carefully analyzed and explained by our genetic counseling team:

  • Positive Result: Indicates presence of CALR3 gene mutation associated with hypertrophic cardiomyopathy. Our genetic counselors will provide detailed guidance on management strategies and family testing recommendations.
  • Negative Result: No pathogenic variants detected in the CALR3 gene. However, regular cardiac monitoring may still be recommended based on family history and clinical presentation.
  • Variant of Uncertain Significance (VUS): Some genetic changes require additional research. Our team will provide ongoing monitoring and updates as scientific knowledge advances.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $500
Regular Price $700

Test Specifications

  • Turnaround Time: 3 to 4 Weeks
  • Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
  • Testing Method: Next-Generation Sequencing (NGS) Technology
  • Specialty: Cardiology and Genetics
  • Department: Cardiovascular Genetics

Pre-Test Requirements

Before scheduling your test, please ensure:

  • Complete clinical history documentation
  • Genetic counseling session to create family pedigree chart
  • Discussion of testing implications with healthcare provider
  • Understanding of potential outcomes and their meanings

Nationwide Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and cardiology specialists ensures you receive comprehensive care regardless of your location.

Take Control of Your Heart Health Today

Don’t wait to understand your genetic heart health risks. Early detection of CALR3 gene mutations can significantly impact your long-term cardiovascular outcomes. Our team of expert genetic counselors and cardiologists are ready to guide you through the testing process and help interpret your results.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your CALR3 Gene Cardiomyopathy Familial Hypertrophic Type 19 NGS Genetic DNA Test and take the first step toward proactive heart health management.